HK1026264A1 - Reagents for the detection and quantification of thryoxine in fluid samples - Google Patents
Reagents for the detection and quantification of thryoxine in fluid samplesInfo
- Publication number
- HK1026264A1 HK1026264A1 HK00103115A HK00103115A HK1026264A1 HK 1026264 A1 HK1026264 A1 HK 1026264A1 HK 00103115 A HK00103115 A HK 00103115A HK 00103115 A HK00103115 A HK 00103115A HK 1026264 A1 HK1026264 A1 HK 1026264A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- thryoxine
- quantification
- reagents
- detection
- fluid samples
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 239000012530 fluid Substances 0.000 title 1
- 238000011002 quantification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/859,775 US5352803A (en) | 1992-03-30 | 1992-03-30 | 5(6)-methyl substituted fluorescein derivatives |
US07/973,140 US5359093A (en) | 1992-03-30 | 1992-11-06 | Reagents and methods for the detection and quantification of thyroxine in fluid samples |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1026264A1 true HK1026264A1 (en) | 2000-12-08 |
Family
ID=27127537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK00103115A HK1026264A1 (en) | 1992-03-30 | 2000-05-24 | Reagents for the detection and quantification of thryoxine in fluid samples |
Country Status (8)
Country | Link |
---|---|
US (2) | US5593896A (fr) |
EP (1) | EP0649533B1 (fr) |
JP (1) | JP3327551B2 (fr) |
CA (1) | CA2131727A1 (fr) |
DE (2) | DE69328622T2 (fr) |
ES (2) | ES2198823T3 (fr) |
HK (1) | HK1026264A1 (fr) |
WO (1) | WO1993020442A1 (fr) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002231736A1 (en) | 2000-12-22 | 2002-07-08 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Use of repulsive guidance molecule (rgm) and its modulators |
US8906864B2 (en) * | 2005-09-30 | 2014-12-09 | AbbVie Deutschland GmbH & Co. KG | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
WO2007111851A1 (fr) * | 2006-03-24 | 2007-10-04 | Aokin Ag | Utilisation d'additifs pour réduire la vitesse d'une réaction de liaison |
US20080102535A1 (en) * | 2006-11-01 | 2008-05-01 | Chace Donald H | Measuring thyroxine levels from dried blood samples using mass spectrometry |
EP2033971A1 (fr) * | 2007-09-06 | 2009-03-11 | Abbott GmbH & Co. KG | Domaines de protéines recombinantes des protéines morphogénétiques osseuses (BMP) de la famille des Repulsive Guidance Molecule (RGM) et leurs fragments fonctionnels ainsi que leur utilisation |
US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
MX2010011955A (es) | 2008-04-29 | 2011-01-21 | Abbott Lab | Inmunoglobulinas de dominio variable doble y usos de las mismas. |
US20090286256A1 (en) * | 2008-05-19 | 2009-11-19 | Abbott Laboratories | Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides |
US20090286329A1 (en) * | 2008-05-19 | 2009-11-19 | Abbott Laboratoires | Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides |
MX2010013239A (es) | 2008-06-03 | 2011-02-24 | Abbott Lab | Inmunoglobulinas de dominio variable doble y usos de las mismas. |
NZ589436A (en) | 2008-06-03 | 2012-12-21 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
US8349325B2 (en) | 2008-12-23 | 2013-01-08 | Abbott Laboratories | Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
JP5836807B2 (ja) | 2009-03-05 | 2015-12-24 | アッヴィ・インコーポレイテッド | Il−17結合タンパク質 |
CA2772014A1 (fr) | 2009-08-31 | 2011-03-03 | Abbott Laboratories | Biomarqueurs pour la prediction d'evenements indesirables cardiaques majeurs et utilisations de ceux-ci |
CN102656190A (zh) * | 2009-12-08 | 2012-09-05 | 雅培股份有限两合公司 | 用于在视网膜神经纤维层变性治疗中使用的针对rgm a蛋白质的单克隆抗体 |
US20110229921A1 (en) * | 2010-03-18 | 2011-09-22 | Abbott Laboratories | METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS |
WO2011129382A1 (fr) | 2010-04-16 | 2011-10-20 | Abbott Japan Co. Ltd. | Procédés et réactifs pour diagnostiquer la polyarthrite rhumatoïde |
KR101848225B1 (ko) | 2010-05-14 | 2018-04-12 | 애브비 인코포레이티드 | Il-1 결합 단백질 |
WO2011163558A1 (fr) | 2010-06-25 | 2011-12-29 | Abbott Laboratories | Matériaux et procédés pour le dosage d'anticorps anti-virus de l'hépatite c (hvc) |
WO2012006500A2 (fr) | 2010-07-08 | 2012-01-12 | Abbott Laboratories | Anticorps monoclonaux contre la protéine de capside du virus de l'hépatite c |
UY33492A (es) | 2010-07-09 | 2012-01-31 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
WO2012018790A2 (fr) | 2010-08-03 | 2012-02-09 | Abbott Laboratories | Immunoglobulines à double domaine variable et utilisations associées |
JP5713602B2 (ja) * | 2010-08-20 | 2015-05-07 | 富士フイルム株式会社 | チロキシンとアルブミンとの結合体を製造する方法 |
US20120115244A1 (en) | 2010-11-09 | 2012-05-10 | Abbott Laboratories | Materials and methods for immunoassay of pterins |
AU2011361720B2 (en) | 2010-12-21 | 2017-04-27 | Abbvie Inc. | IL-1 -alpha and -beta bispecific dual variable domain immunoglobulins and their use |
EP2771361A1 (fr) | 2011-10-24 | 2014-09-03 | AbbVie Inc. | Agents de liaison immunologique bispécifiques contre le tnf et l'il-17 |
RU2014120981A (ru) | 2011-10-24 | 2015-12-10 | Эббви Инк. | Иммунные связывающие агенты против склеростина |
US10118958B2 (en) | 2011-12-14 | 2018-11-06 | AbbVie Deutschland GmbH & Co. KG | Composition and method for the diagnosis and treatment of iron-related disorders |
JP6336397B2 (ja) | 2011-12-14 | 2018-06-06 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | 鉄関連障害を診断および治療するための組成物および方法 |
US8993248B2 (en) | 2011-12-31 | 2015-03-31 | Abbott Laboratories | Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use |
JP6271441B2 (ja) | 2012-01-27 | 2018-01-31 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | 神経突起変性に関連する疾患を診断および治療するための組成物および方法 |
JP2015512892A (ja) | 2012-03-13 | 2015-04-30 | アッヴィ・インコーポレイテッド | V1bアンタゴニスト療法について対象を選択または同定するための方法 |
US9670276B2 (en) | 2012-07-12 | 2017-06-06 | Abbvie Inc. | IL-1 binding proteins |
GB2546213B (en) | 2013-02-02 | 2017-12-06 | Univ Duke | Method of isolating circulating tumour cells |
US9194873B2 (en) | 2013-03-14 | 2015-11-24 | Abbott Laboratories | HCV antigen-antibody combination assay and methods and compositions for use therein |
JP2016512241A (ja) | 2013-03-14 | 2016-04-25 | アボット・ラボラトリーズAbbott Laboratories | 改良された抗体検出のためのhcvns3組換え抗原およびこの突然変異体 |
CN113549148A (zh) | 2013-03-14 | 2021-10-26 | 雅培制药有限公司 | Hcv核心脂质结合结构域单克隆抗体 |
US9157910B2 (en) | 2013-03-15 | 2015-10-13 | Abbott Laboratories | Assay with increased dynamic range |
US9469686B2 (en) | 2013-03-15 | 2016-10-18 | Abbott Laboratories | Anti-GP73 monoclonal antibodies and methods of obtaining the same |
US9005901B2 (en) | 2013-03-15 | 2015-04-14 | Abbott Laboratories | Assay with internal calibration |
WO2015031626A1 (fr) | 2013-08-28 | 2015-03-05 | Abbvie Inc. | Dosage de cmet soluble |
WO2015200833A2 (fr) | 2014-06-27 | 2015-12-30 | Abbott Laboratories | Compositions et procédés pour détecter le pegivirus humain 2 (hp-v-2) |
CN104262250A (zh) * | 2014-09-01 | 2015-01-07 | 深圳市美凯特科技有限公司 | 三碘代甲状腺素半抗原发光标记物及合成方法 |
CN107110868B (zh) | 2014-10-29 | 2020-08-21 | 雅培制药有限公司 | 采用ns3捕获肽的受试者抗hcv抗体检测测定 |
ES2870989T3 (es) | 2015-04-03 | 2021-10-28 | Abbott Lab | Dispositivos y métodos para el análisis de muestras |
EP3277427A1 (fr) | 2015-04-03 | 2018-02-07 | Abbott Laboratories | Dispositifs et procédés d'analyse d'échantillon |
US20170089905A1 (en) | 2015-09-28 | 2017-03-30 | Abbott Japan Co., Ltd. | Methods of diagnosing hepatocellular carcinoma and pancreatic cancer |
EP3519825A1 (fr) | 2016-10-03 | 2019-08-07 | Abbott Laboratories | Procédés améliorés d'évaluation de l'état de gfap dans des échantillons de patient |
CN109863396B (zh) | 2016-10-05 | 2021-11-05 | 雅培实验室 | 用于样品分析的装置和方法 |
WO2018175942A1 (fr) | 2017-03-23 | 2018-09-27 | Abbott Laboratories | Méthodes d'aide au diagnostic et à la détermination de l'étendue d'une lésion cérébrale traumatique chez un sujet humain à l'aide du biomarqueur précoce hydrolase carboxy-terminale d'ubiquitine l1 |
CN110546513A (zh) | 2017-04-15 | 2019-12-06 | 雅培实验室 | 使用早期生物标记物帮助超急性诊断和确定人类受试者中的创伤性脑损伤的方法 |
AU2018256845B2 (en) | 2017-04-28 | 2024-03-14 | Abbott Laboratories | Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject |
CN110651190A (zh) | 2017-05-25 | 2020-01-03 | 雅培实验室 | 用早期生物标记物帮助确定是否对已遭受或可能已遭受头部损伤的人受试者执行成像的方法 |
CN110720041B (zh) | 2017-05-30 | 2024-04-26 | 雅培实验室 | 用心肌肌钙蛋白i和早期生物标记物帮助诊断和评价人受试者中轻度创伤性脑损伤的方法 |
EP3649474A1 (fr) | 2017-07-03 | 2020-05-13 | Abbott Laboratories | Procédés améliorés de mesure de niveaux d'hydrolase à terminaison carboxy d'ubiquitine l1 dans le sang |
US11661447B2 (en) | 2017-08-03 | 2023-05-30 | The Cleveland Clinic Foundation | Human β2-glycoprotein I expression |
JP7344801B2 (ja) | 2017-12-09 | 2023-09-14 | アボット・ラボラトリーズ | グリア原線維性酸性タンパク質(gfap)及び/又はユビキチンカルボキシ末端ヒドロラーゼl1(uch-l1)を使用する、整形外科損傷を負っており、軽度外傷性脳損傷(tbi)などの頭部への損傷を負ったか又は負った可能性がある対象についての診断及び査定の一助となるための方法 |
JP7379165B2 (ja) | 2017-12-09 | 2023-11-14 | アボット・ラボラトリーズ | Gfapとuch-l1との組合せを使用する、ヒト対象における外傷性脳損傷を診断及び査定する一助となるための方法 |
CA3084064A1 (fr) | 2017-12-29 | 2019-07-04 | Abbott Laboratories | Nouveaux biomarqueurs et methodes de diagnostic et d'evaluation d'une lesion cerebrale d'origine traumatique |
US11249091B2 (en) | 2018-02-22 | 2022-02-15 | The Cleveland Clinic Foundation | Detection of glucuronidated and 3-bromotyrosine |
WO2019213583A1 (fr) | 2018-05-04 | 2019-11-07 | Abbott Laboratories | Procédé d'échantillonnage séquentiel pour améliorer la sensibilité et la cinétique de dosage immunologique d'échantillons de faible volume |
EP3931573A1 (fr) | 2019-03-01 | 2022-01-05 | Abbott Laboratories | Procédés de prédiction d'événements cardiovasculaires indésirables majeurs chez des sujets atteints d'une coronaropathie |
CA3175523A1 (fr) | 2020-04-13 | 2021-10-21 | Antti Virtanen | Procedes, complexes et kits pour detecter ou determiner une quantite d'un anticorps a .beta.-coronavirus dans un echantillon |
KR20230042301A (ko) | 2020-08-04 | 2023-03-28 | 애벗트 라보라토리이즈 | 샘플에서 sars-cov-2 단백질을 검출하기 위한 개선된 방법 및 키트 |
US20220170948A1 (en) | 2020-12-01 | 2022-06-02 | Abbott Laboratories | Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi |
WO2023102384A1 (fr) | 2021-11-30 | 2023-06-08 | Abbott Laboratories | Utilisation d'un ou de plusieurs biomarqueurs pour déterminer un traumatisme crânien (tbi) chez un sujet ayant été soumis à un balayage de tomodensitométrie assistée par ordinateur de la tête ne démontrant par de tbi |
WO2022147147A1 (fr) | 2020-12-30 | 2022-07-07 | Abbott Laboratories | Procédés pour déterminer un antigène sras-cov-2 et anticorps anti-sras-cov-2 dans un échantillon |
WO2022232550A1 (fr) | 2021-04-29 | 2022-11-03 | Abbott Laboratories | Systèmes et méthodes de regroupement d'échantillons destiné à une analyse à haut rendement |
US20220381796A1 (en) | 2021-05-18 | 2022-12-01 | Abbott Laboratories | Methods of evaluating brain injury in a pediatric subject |
US20240118279A1 (en) | 2021-06-14 | 2024-04-11 | Abbott Laboratories | Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind |
EP4392783A1 (fr) | 2021-08-27 | 2024-07-03 | Abbott Laboratories | Méthodes de détection d'immunoglobuline g, de sous-classe 4 (igg4), dans un échantillon biologique |
AU2022339759A1 (en) | 2021-08-31 | 2024-03-07 | Abbott Laboratories | Methods and systems of diagnosing brain injury |
AU2022354059A1 (en) | 2021-09-30 | 2024-03-28 | Abbott Laboratories | Methods and systems of diagnosing brain injury |
CA3240822A1 (fr) | 2021-12-17 | 2023-06-22 | Tony Lee | Systemes et procedes de determination d'uch-l1, de gfap et d'autres biomarqueurs dans des echantillons de sang |
WO2023129942A1 (fr) | 2021-12-28 | 2023-07-06 | Abbott Laboratories | Utilisation de biomarqueurs pour déterminer une lésion cérébrale traumatique (tbi) subaiguë chez un sujet ayant subi un tomodensitogramme (ct) de la tête négatif pour une tbi ou n'ayant pas subi de tomodensitogramme |
WO2024006876A1 (fr) | 2022-06-29 | 2024-01-04 | Abbott Laboratories | Systèmes et analyses magnétiques hors laboratoire pour déterminer une gfap dans des échantillons biologiques |
WO2024059708A1 (fr) | 2022-09-15 | 2024-03-21 | Abbott Laboratories | Biomarqueurs et méthodes de différenciation entre une lésion cérébrale traumatique légère et très légère |
US20240167075A1 (en) | 2022-11-17 | 2024-05-23 | Regeneron Pharmaceuticals, Inc. | Methods for assaying enzyme activity |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3714344A (en) * | 1969-05-01 | 1973-01-30 | Mallinckrodt Chemical Works | Method for determining thyroxine in blood serum and reagent therefor |
US4040907A (en) * | 1974-06-20 | 1977-08-09 | Syva Company | Iodothyronine enzyme conjugates |
US4111656A (en) * | 1975-06-26 | 1978-09-05 | Mallinckrodt, Inc. | Radioimmunoassay methods for the determination of l-triiodothyronine and thyroxine |
US4307071A (en) * | 1977-08-02 | 1981-12-22 | Kallestad Laboratories, Inc. | Analytical reagent and method |
US4329461A (en) * | 1980-01-11 | 1982-05-11 | Syva Company | Fluorescent thyroid hormone conjugates and their uses |
US4391795A (en) * | 1980-03-21 | 1983-07-05 | Becton Dickinson And Company | Assay for free thyroid hormone |
DE73865T1 (de) * | 1981-09-11 | 1983-07-21 | Amersham International Plc, Amersham, Buckinghamshire | Iodthyronin-derivate und ihre anwendung zur bestimmung freier iodthyronin-verbindungen. |
US4668640A (en) * | 1981-12-11 | 1987-05-26 | Abbott Laboratories | Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins |
US4510251A (en) * | 1982-11-08 | 1985-04-09 | Abbott Laboratories | Fluorescent polarization assay for ligands using aminomethylfluorescein derivatives as tracers |
US4476228A (en) * | 1982-11-08 | 1984-10-09 | Abbott Laboratories | Determination of unsaturated thyroxine binding protein sites using fluorescence polarization techniques |
US4476229A (en) * | 1982-11-08 | 1984-10-09 | Abbott Laboratories | Substituted carboxyfluoresceins |
US4614823A (en) * | 1982-11-08 | 1986-09-30 | Abbott Laboratories | Aminomethylfluorescein derivatives |
US4636478A (en) * | 1984-07-16 | 1987-01-13 | Becton, Dickinson And Company | Monoclonal antibodies recognizing L-thyroxine |
DE3504406A1 (de) * | 1985-02-08 | 1986-08-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur bestimmung der bindungskapazitaet des thyroxin bindenden globulins |
DE3751673T2 (de) * | 1986-10-24 | 1996-08-01 | Abbott Lab | Test, Indikatoren, Immunogene und Antikörper für Benzodiazepine |
US4912208A (en) * | 1987-06-29 | 1990-03-27 | Abbott Laboratories | Fluorophores for encapsulation into liposomes |
US5145790A (en) * | 1990-05-04 | 1992-09-08 | Abbott Laboratories | Reagents and method for detecting polychlorinated biphenyls |
DK0473961T3 (da) * | 1990-08-15 | 1996-07-01 | Abbott Lab | Immunoassay-reagenser og fremgangsmåde til bestemmelse af cyklosporin |
EP0603266B1 (fr) * | 1991-08-23 | 1999-05-12 | Molecular Probes, Inc. | Emploi de derives haloalkyle de molecules rapporteuses dans l'analyse de l'activite metabolique dans des cellules |
US5296599A (en) * | 1991-09-19 | 1994-03-22 | Millipore Corporation | Activated carbamates compounds |
-
1993
- 1993-03-29 WO PCT/US1993/002909 patent/WO1993020442A1/fr active IP Right Grant
- 1993-03-29 ES ES99115138T patent/ES2198823T3/es not_active Expired - Lifetime
- 1993-03-29 DE DE69328622T patent/DE69328622T2/de not_active Expired - Lifetime
- 1993-03-29 DE DE69332988T patent/DE69332988T2/de not_active Expired - Lifetime
- 1993-03-29 ES ES93908638T patent/ES2148225T3/es not_active Expired - Lifetime
- 1993-03-29 CA CA002131727A patent/CA2131727A1/fr not_active Abandoned
- 1993-03-29 EP EP93908638A patent/EP0649533B1/fr not_active Expired - Lifetime
- 1993-03-29 JP JP51759693A patent/JP3327551B2/ja not_active Expired - Lifetime
-
1994
- 1994-07-13 US US08/275,064 patent/US5593896A/en not_active Expired - Lifetime
-
1995
- 1995-05-18 US US08/443,833 patent/US5648272A/en not_active Expired - Lifetime
-
2000
- 2000-05-24 HK HK00103115A patent/HK1026264A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5648272A (en) | 1997-07-15 |
ES2148225T3 (es) | 2000-10-16 |
CA2131727A1 (fr) | 1993-10-14 |
DE69328622D1 (de) | 2000-06-15 |
DE69332988T2 (de) | 2004-05-19 |
DE69332988D1 (de) | 2003-06-18 |
JPH07505714A (ja) | 1995-06-22 |
ES2198823T3 (es) | 2004-02-01 |
EP0649533B1 (fr) | 2000-05-10 |
EP0649533A4 (fr) | 1996-08-21 |
WO1993020442A1 (fr) | 1993-10-14 |
DE69328622T2 (de) | 2001-02-08 |
JP3327551B2 (ja) | 2002-09-24 |
EP0649533A1 (fr) | 1995-04-26 |
US5593896A (en) | 1997-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1026264A1 (en) | Reagents for the detection and quantification of thryoxine in fluid samples | |
AU2418192A (en) | Method and device for detecting the presence of analyte in a sample | |
GB2114737B (en) | An integral multilayer analytical elememt for ammonia determination and use thereof in detection of ammonia or an ammonia-forming substrate | |
HUP9702463A3 (en) | Process and compounds for the magnetorelaxometric detection of analytes and use thereof | |
AU6609994A (en) | Analyte detection device and process | |
AU5964494A (en) | Assays and kits for detecting analytes in the presence of cross-reacting substances | |
IL105813A (en) | Method and system for sampling and determining the presence of compounds in containers | |
GB9218946D0 (en) | Process for the detection and quantification of corrosion and scale inhibitors in produced well fluids | |
EP0521421A3 (en) | Method for analysis of liquid samples and substrate for analysis of liquid sample employed in the method | |
AU4716093A (en) | Analytical method for the detection and measurement of paracetamol | |
AU1186695A (en) | Reagents and methods for the detection of methotrexate | |
IL106273A0 (en) | Rapid detection of biopolymers in stained specimens | |
GB9215741D0 (en) | Method and apparatus for the measurement of pollutants in liquids | |
IL117182A (en) | Method and reagent for the specific determination of ldl in serum samples | |
GB9515964D0 (en) | Detecting characteristics of liquids in pipes | |
AU3190389A (en) | Composition for simple detection and/or quantification of antigenic substances in body liquids | |
AU6886094A (en) | Analyte detection device and process | |
ZA944024B (en) | Immunoassay reagents and methods for detecting brequinar and analoges | |
EP0572968A3 (fr) | Procédé et dispositif pour la préparation des échantillons liquides pour l'analyse. | |
EP0410893A3 (en) | Determination and detection of antibody and its immunoglobulin class | |
EP0550883A3 (en) | Method and reagents for determining the presence of giardia lamblia | |
EP0409345A3 (en) | Analytical element and method for the determination of creatinine | |
EP0601275A3 (fr) | Procédé et appareil pour ajouter automatiquement des réactifs liquides à un conteneur. | |
EP0579343A3 (fr) | Procédé et dispositif pour mesurer des analytes dans des liquides. | |
IL86520A0 (en) | Method for the detection of anions and analytical reagents therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080329 |